5-83065056-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_174909.5(TMEM167A):​c.65C>G​(p.Ala22Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 30)

Consequence

TMEM167A
NM_174909.5 missense

Scores

6
8
4

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 9.60
Variant links:
Genes affected
TMEM167A (HGNC:28330): (transmembrane protein 167A) Involved in constitutive secretory pathway. Located in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TMEM167ANM_174909.5 linkuse as main transcriptc.65C>G p.Ala22Gly missense_variant 2/4 ENST00000502346.2 NP_777569.1 Q8TBQ9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TMEM167AENST00000502346.2 linkuse as main transcriptc.65C>G p.Ala22Gly missense_variant 2/41 NM_174909.5 ENSP00000424707.1 Q8TBQ9

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
30

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 03, 2024The c.65C>G (p.A22G) alteration is located in exon 2 (coding exon 2) of the TMEM167A gene. This alteration results from a C to G substitution at nucleotide position 65, causing the alanine (A) at amino acid position 22 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.69
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Uncertain
0.050
CADD
Pathogenic
29
DANN
Uncertain
1.0
DEOGEN2
Benign
0.42
T
Eigen
Uncertain
0.56
Eigen_PC
Pathogenic
0.67
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Benign
0.022
T
MetaRNN
Uncertain
0.49
T
MetaSVM
Benign
-0.47
T
PrimateAI
Pathogenic
0.86
D
PROVEAN
Uncertain
-2.9
D
REVEL
Uncertain
0.53
Sift
Uncertain
0.027
D
Sift4G
Uncertain
0.0080
D
Polyphen
0.53
P
Vest4
0.62
MutPred
0.58
Loss of stability (P = 0.1452);
MVP
0.20
MPC
0.55
ClinPred
0.98
D
GERP RS
5.8
Varity_R
0.45
gMVP
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr5-82360875; API